A scathing report by the General Accountability Office, a federal watchdog organization, exposes serious flaws in the needed data collection by the FDA for fast-tracked drugs. Continue reading
The post Probe Shows FDA as Laggard in Drug Trial Follow-ups appeared first on American Council on Science and Health.